New guidelines warn of epilepsy drug's use during pregnancy

04/27/2009 | WebMD

The American Academy of Neurology and the American Epilepsy Society released guidelines advising pregnant women against the use of epilepsy drug valproate as well as seizure medicines phenytoin and phenobarbital because they have been linked to an increased risk of birth defects. The guidelines were issued after a study showed that children whose mothers took valproate during pregnancy had lower IQ scores compared with those exposed to other epilepsy treatments. Valproate maker Abbott Laboratories said medical providers should weigh the risk and benefits of the drug before recommending it to patients.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ